Testing a new shot for seasonal allergies not controlled by sprays
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests a new injection called GR1802 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments. It aims to see if this medicine can help reduce symptoms during pollen season.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had seasonal allergies (hay fever) for at least 2 years.
- Your symptoms are not well controlled with nasal steroid sprays or other allergy medicines during past pollen seasons.
- You weigh at least 30kg (about 66 pounds).
- You do not have poorly controlled asthma or serious infections like active tuberculosis.
- You have never taken a medicine called an anti-IL4Rα antibody (like dupilumab).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
This trial tests a new way to treat allergies by injecting allergy medicine directly into the tonsils. It may help people with hay fever who haven't gotten relief from standard treatments or want to avoid long-term medication.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
Hear when a new Allergic Rhinitis, Seasonal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.